TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Enorama Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
16,262
|
1,376
|
6,477 |
| Financial expenses |
3,084
|
3,636
|
1,975 |
| Earnings before taxes |
-45,177
|
-45,194
|
-39,757 |
| EBITDA |
-27,953
|
-39,082
|
-35,881 |
| Total assets |
16,391
|
34,833
|
46,086 |
| Current assets |
15,634
|
13,133
|
11,116 |
| Current liabilities |
8,344
|
10,351
|
11,754 |
| Equity capital |
8,047
|
19,793
|
29,819 |
| - share capital |
9,745
|
6,477
|
1,382 |
| Employees (average) |
5
|
5
|
9 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
49.1%
|
56.8%
|
64.7% |
| Turnover per employee |
3,252
|
275
|
720 |
| Profit as a percentage of turnover |
-277.8%
|
-3284.4%
|
-613.8% |
| Return on assets (ROA) |
-256.8%
|
-119.3%
|
-82.0% |
| Current ratio |
187.4%
|
126.9%
|
94.6% |
| Return on equity (ROE) |
-561.4%
|
-228.3%
|
-133.3% |
| Change turnover |
14,861
|
-5,561
|
-3,962 |
| Change turnover % |
1061%
|
-80%
|
-38% |
| Chg. No. of employees |
0
|
-4
|
-1 |
| Chg. No. of employees % |
0%
|
-44%
|
-10% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.